Who
Jill Buck
Chief Development Officer
Company insider
Files Form 4 as: Chief Development Officer, enGene Therapeutics; EVP, GM Gene Therapy, Alaunos Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $214K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Jan 2020
- Last trade
- 30 Jan 2026
- Last filed
- 3 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jan 2026filed 3 Feb 2026 | ENGN enGene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | ENGN enGene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —195,000 at $0.00 | filing |
| 8 Jul 2025filed 10 Jul 2025 | ENGN enGene Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 4 Mar 2021filed 8 Mar 2021 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | —31,500 at $0.00 | filing |
| 4 Mar 2021filed 8 Mar 2021 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —236,250 at $0.00 | filing |
| 8 Jan 2021filed 12 Jan 2021 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Sold | $87K27,894 at $3.12 | filing |
| 29 Jan 2020filed 31 Jan 2020 | TCRT Alaunos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —82,600 at $0.00 | filing |
| 29 Jan 2020filed 31 Jan 2020 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Code A | —53,700 at $0.00 | filing |
| 2 Jan 2020filed 3 Jan 2020 | TCRT Alaunos TherapeuticsBiotechnology | SEC FORM 4 Sold | $127K27,923 at $4.55 | filing |
News
Biotech Stock Alaunos Therapeutics (NASDAQ: TCRT) Sees Triple Digit Gains on Acquisition and FundingTCRT · investorideas.com · 13 Oct 2026Alaunos Therapeutics Announces Acquisition of Velaris TherapeuticsTCRT · manilatimes.net · 13 Oct 2026
0 headlines in the last 90 days name Jill Buck; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.